These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 17931461

  • 1. Evaluation of the potential for steady-state pharmacokinetic interaction between vildagliptin and simvastatin in healthy subjects.
    Ayalasomayajula SP, Dole K, He YL, Ligueros-Saylan M, Wang Y, Campestrini J, Humbert H, Sunkara G.
    Curr Med Res Opin; 2007 Dec; 23(12):2913-20. PubMed ID: 17931461
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of food on the pharmacokinetics of a vildagliptin/metformin (50/1000 mg) fixed-dose combination tablet in healthy volunteers.
    He YL, Flannery B, Campestrini J, Leon S, Zinny MA, Ligueros-Saylan M, Jarugula V.
    Curr Med Res Opin; 2008 Jun; 24(6):1703-9. PubMed ID: 18471347
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of pharmacokinetic interactions between vildagliptin and digoxin in healthy volunteers.
    He YL, Sabo R, Sunkara G, Bizot MN, Riviere GJ, Leon S, Ligueros-Saylan M, Dole WP, Howard D.
    J Clin Pharmacol; 2007 Aug; 47(8):998-1004. PubMed ID: 17660482
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    He YL, Sabo R, Riviere GJ, Sunkara G, Leon S, Ligueros-Saylan M, Rosenberg M, Dole WP, Howard D.
    Curr Med Res Opin; 2007 May; 23(5):1131-8. PubMed ID: 17519080
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Absorption, metabolism, and excretion of [14C]vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans.
    He H, Tran P, Yin H, Smith H, Batard Y, Wang L, Einolf H, Gu H, Mangold JB, Fischer V, Howard D.
    Drug Metab Dispos; 2009 Mar; 37(3):536-44. PubMed ID: 19074975
    [Abstract] [Full Text] [Related]

  • 11. Study of the pharmacokinetic interaction of vildagliptin and metformin in patients with type 2 diabetes.
    He YL, Sabo R, Picard F, Wang Y, Herron J, Ligueros-Saylan M, Dole WP.
    Curr Med Res Opin; 2009 May; 25(5):1265-72. PubMed ID: 19364302
    [Abstract] [Full Text] [Related]

  • 12. Simvastatin does not have a clinically significant pharmacokinetic interaction with fenofibrate in humans.
    Bergman AJ, Murphy G, Burke J, Zhao JJ, Valesky R, Liu L, Lasseter KC, He W, Prueksaritanont T, Qiu Y, Hartford A, Vega JM, Paolini JF.
    J Clin Pharmacol; 2004 Sep; 44(9):1054-62. PubMed ID: 15317833
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic and pharmacodynamic interaction of vildagliptin and voglibose in Japanese patients with Type 2 diabetes.
    Yamaguchi M, Saji T, Mita S, Kulmatycki K, He YL, Furihata K, Sekiguchi K.
    Int J Clin Pharmacol Ther; 2013 Aug; 51(8):641-51. PubMed ID: 23782587
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of a pharmacokinetic interaction between valsartan and simvastatin in healthy subjects.
    Sunkara G, Reynolds CV, Pommier F, Humbert H, Yeh C, Prasad P.
    Curr Med Res Opin; 2007 Mar; 23(3):631-40. PubMed ID: 17355744
    [Abstract] [Full Text] [Related]

  • 15. Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs.
    He H, Tran P, Yin H, Smith H, Flood D, Kramp R, Filipeck R, Fischer V, Howard D.
    Drug Metab Dispos; 2009 Mar; 37(3):545-54. PubMed ID: 19074976
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hepatic Dipeptidyl Peptidase-4 Controls Pharmacokinetics of Vildagliptin In Vivo.
    Asakura M, Fukami T, Nakajima M, Fujii H, Atsuda K, Itoh T, Fujiwara R.
    Drug Metab Dispos; 2017 Feb; 45(2):237-245. PubMed ID: 27895112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.